jRCT2031220065暂停不适用
Post-marketing surveillance of LUTATHERA Injection (All Case Study)
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 入组人数
- 300
- 主要终点
- Case composition
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- No limit 至 No limit（—）
- 性别
- All
入选标准
- •All patients who received LUTATHERA Injection
排除标准
- 未提供
结局指标
主要结局
Case composition
- Number of registered cases - Number of cases for which questionnaires were collected - Number of cases for safety analysis - Number of cases excluded from analysis and reasons for exclusion
Safety items
- The rate of adverse drug reactions - The rate of serious adverse drug reactions - The rate of adverse drug reactions related to the safety specifications in this study
Others
- Treatment results with this drug
次要结局
未报告次要终点
研究者
相似试验
暂停
不适用
Post-marketing surveillance of LUTATHERA Injection (All Case Study)Somatostatin receptor-positive neuroendocrine tumorsJPRN-jRCT2031220065Maki Keiji300
已完成
不适用
A Post Marketing Surveillance on Lutathera® in Patients With Somatostatin Receptor Positive Gastroenteropancreatic Neuroendocrine Tumor in KoreaSomatostatin Receptor-positive GEP-NETNCT04946305Novartis Pharmaceuticals89
已完成
不适用
Post-marketing surveillance for refractory uveoretinitis associated with Behcet's disease under Remicade treatmentBehcet's diseaseJPRN-UMIN000027733Mitsubishi Tanabe Pharma Corporation100
已完成
不适用
Post-market clinical follow-up investigation of the marketed Extended Range of Vision IOL (Intraocular lens)h25H26Senile cataractOther cataractDRKS00005742Abbott Medical Optics Inc.147
招募中
Unknown
All case study of Lenvima Capsulenresectable thyroid cancerJPRN-jRCT1080222856Eisai Co., Ltd.400